For authors

Prepare research that can be assessed.

A practical route through scope, manuscript files, scientific reporting and the declarations needed for a fair review.

AI and research integrity

Prepare an accurate AI-use declaration, verify references and explain the provenance of figures, data and code.

Read the practical guide

Manuscript Pre-check

Recommended before submission. Check sections, declarations, citations and references, then prepare a Word draft with this journal’s template.

Check your manuscript

Manuscript submissions

The journal is led by Editor-in-Chief Dr. Thierry Oscar Codjo Edoh. Manuscript reception remains closed while the submission workflow is prepared. You may use the guidance and Manuscript Pre-check to prepare your work; preparation is not a journal submission. The opening date and authorised submission route will be announced here.

Author instructions and submission resources

Downloading a template or preparing evidence does not submit a manuscript. The formal submission route will be announced when the journal opens.

01

Check the fit

Identify the principal contribution and its fit with the journal’s scope.

02

Prepare the files

Separate the anonymised manuscript from author details.

03

Explain the evidence

Document methods, access conditions and limitations.

04

Complete declarations

Check authorship, ethics, support and related work.

Working Word resources

Use these editable files alongside the instructions below. They are preparation resources; they do not create an active submission.

WORD · DOCX

Manuscript template

Prepare the main manuscript and keep author identities in the separate title page.

Download manuscript template
WORD · DOCX

Title page

Record the author list, affiliations, contributions and relevant declarations separately.

Download title page
WORD · DOCX

Cover letter

Explain the contribution, journal fit and related work for editorial assessment.

Download cover letter

Preparing the submission files

Prepare an anonymised manuscript, a separate title page, a cover letter and any supporting files needed to assess the work. The title page should give the full journal title, manuscript title, article type, author names and affiliations, corresponding author details, contribution statement and relevant declarations. Keep identities and identifying acknowledgements out of the review manuscript. Anonymise document properties and explain any repository link that could reveal authorship. Ethics, data-access and methodological declarations needed to assess the science must remain in anonymised form in the review manuscript. Provide identifying approvals or other confidential evidence separately through the authorised editorial route.

Prepare an editable DOCX manuscript using the journal structure; a review PDF may accompany it. Authors using LaTeX or another specialist format should seek an agreed alternative route before submission and provide a compiled review PDF and source when requested. Supply original figure files and an accurate reference list for production. Initial submissions may use a consistent readable reference style. The final house style is specified during production. References to data and software should identify the version or release and a persistent identifier where available.

Manuscript structure and length

Use a specific title, an informative abstract and descriptive keywords. State the research question, its relationship to prior work, the methods and assumptions, the evidence, limitations and conclusions. For empirical work, distinguish results from interpretation. For theoretical, conceptual or qualitative work, use a structure that makes the reasoning and evidence traceable. Include all applicable declarations and cite supplementary material in the manuscript.

There is no fixed initial-submission word limit in this guide. Provide a word count and use the length needed for a complete, focused account. The editor may request shortening or restructuring. A later published article-type limit will apply to submissions received after its stated effective date; any exceptional change for a manuscript already under consideration must be communicated to its authors.

Submission and revision correspondence

A preparation file or saved evidence record does not constitute a journal submission. Formal submission requires the journal's announced submission route, author approval and completion of the required declarations. Authors should use the manuscript reference in subsequent correspondence and identify the version to which a query relates.

A revised submission should include an updated anonymised manuscript, any revised supporting files and a response addressing every editorial and reviewer point. Identify where changes were made and explain any reasoned disagreement. Keep the response professional and provide evidence for disputed technical issues. Do not silently substitute datasets, analyses or author lists; disclose consequential changes for editorial assessment.

Journal-specific standards

Scientific reporting

Use the guidance relevant to your design. A formal, conceptual or behavioural study should not add unrelated experiments merely to resemble another article type.

State the health question and intended use

Explain who or what may benefit, the care or population context and the gap addressed. For a technology, identify whether the work concerns development, analytical validation, clinical validation, implementation or evaluation of outcomes. These stages answer different questions. Describe the proposed role of the technology and the decisions it could support without presenting investigational findings as established clinical practice.

Match reporting to the research design

Choose reporting guidance appropriate to the design and provide a completed checklist where applicable. Examples include CONSORT for randomised trials, STROBE for observational research, PRISMA for evidence syntheses and SRQR or COREQ for relevant qualitative designs. Use relevant extensions for AI, diagnostics, prediction or economic evaluation. A reporting checklist helps readers locate information; it does not establish that the design or conclusions are valid.

Explain ethics review and consent separately

Identify the responsible ethics body and approval or exemption reference, or explain the documented basis for a determination that review was not required. State how participation consent was obtained or waived. Research permission, participation consent and consent to publish identifiable information are distinct matters. Describe additional safeguards for vulnerable participants. For relevant animal or biological-material research, provide the applicable welfare, review and collection permissions.

Make trial plans and changes examinable

For research meeting the definition of a clinical trial, state its registry, identifier and registration timing. Prospective registration should precede participant enrolment. Explain any late registration and its implications for selective reporting. Supply the protocol and relevant statistical analysis plan, with amendment dates and reasons. Account for changed outcomes, recruitment targets and analyses. Clearly label exploratory or post-hoc analyses and identify relevant harms, withdrawals and missing outcomes.

Report quantitative qualitative and mixed methods

For quantitative work, explain sample-size reasoning, outcome definitions, missing data, exclusions, confounding, multiplicity and uncertainty. Report effect sizes and intervals where appropriate. For qualitative work, identify the methodological approach, researcher position, sampling, setting, collection, analysis and evidence supporting interpretations. Explain the basis for judging the adequacy of the material. Mixed-method studies should describe why approaches were combined and how findings were integrated.

Describe patient public and community involvement

Include a statement explaining whether and how patients, carers or public representatives influenced the question, design, recruitment, interpretation or dissemination. If there was no involvement, state this without inventing participation. Distinguish involvement in designing research from enrolment as a study participant. For research involving local or Indigenous communities, explain relevant permissions, community priorities, collaboration and decisions about knowledge, data and dissemination.

Describe populations and the limits of generalisation

Explain recruitment, inclusion criteria and the basis for population categories, including sex, gender, ethnicity, age or disability where relevant. Use terms appropriate to the communities concerned and distinguish concepts that measure different attributes. Justify exclusions or restricted populations. Examine important subgroup differences when the design and data support such analysis, and describe limits when they do not. Avoid treating a convenience sample as representative of every intended user.

Provide a workable route to data and materials

Explain data provenance, permissions, de-identification and access conditions for both newly collected and reused material. Public availability does not remove consent, licence or ethical obligations. For controlled data, specify the reason for restriction, available materials, eligible applicants, request contact, assessment process, expected response period, permitted uses and access duration where known. Describe relevant agreements and how authorised reviewers can examine the evidence. Report material, reagent or cell-line provenance and authentication when applicable.

Evaluate clinical AI and analytical technologies

Separate development, tuning and testing at the level needed to prevent leakage, including repeated observations from the same person or institution. Explain reference standards, comparators, calibration, discrimination, uncertainty and subgroup assessment as relevant. State the independence and setting of validation and any limits on transportability. External or prospective evaluation should match the deployment claims made. Describe human oversight, failure modes and what remains untested about usability, safety or patient benefit.

Communicate outcomes and uncertainty responsibly

Explain the practical meaning of findings for patients, clinicians or services without overstating causation, effectiveness or readiness. Describe important limitations, including small samples, incomplete follow-up or constrained evaluation environments. Identify the relationship between statistical significance and clinical importance. A concise accessible explanation of the findings can support communication with participants and communities; it must retain the uncertainty and limits of the research.

Declaration examples

Adapt these examples to what actually occurred. Keep science-relevant information in the anonymised manuscript and provide identifying evidence separately when needed.

Ethics review and participation consent

The study was reviewed by [full ethics body] under reference [identifier], dated [date]. Participation consent was [obtained in the stated form/waived by the named body]. The basis and scope of any waiver were [explanation]. Replace each field with the actual determination.

Consent for publication

The manuscript contains [description of potentially identifiable material]. Written consent for publication was obtained from [the participant or authorised representative] for [scope of material]. Where no identifiable material is included, state the appropriate basis instead of claiming consent that was not obtained.

Patient and public involvement

[Patients/carers/public representatives] contributed to [specific stages and decisions]. Their involvement changed [specific aspect, if applicable]. Findings will be shared through [appropriate route]. Alternatively: Patients and public representatives were not involved in the design or conduct of this study; [brief explanation where useful].

Controlled access to health data

The data contain [reason for restriction] and cannot be released publicly under [actual permission or agreement]. Requests for [specified materials] may be assessed by [responsible body] through [verified route], using [eligibility and permitted-use criteria]. The anticipated response period and access duration are [actual arrangements].

Protocol and analysis changes

The study was registered at [registry] under [identifier] on [date], [before/after] first enrolment. Changes from the protocol or analysis plan were [description], made on [date] for [reason]. Analyses not specified in advance are identified as exploratory in [location].

Common questions

Does a study need to use AI or a digital technology?

No. The scope includes clinical, population, behavioural, pharmaceutical, nursing, allied-health and health-service research. Every submission should establish its relevance to human health or care and an appropriate research contribution.

Can a study use an existing public health dataset?

Yes, where its use is permitted and appropriate. Explain the source, version, original and secondary-use permissions, relevant ethical determination and analytical contribution. A public download link alone does not settle every ethical or licensing question.

Must all participant data be openly downloadable?

No. Legitimate privacy, consent, community-governance and other restrictions must be respected. Provide a precise availability statement and an appropriate route for examining supporting evidence, rather than promising access that cannot lawfully or ethically be given.

Can a pilot study or a study with null findings be considered?

Yes, if the question, design and reporting provide useful evidence. Explain the developmental or confirmatory purpose and the limits of precision. A pilot should not claim definitive effectiveness merely because a small analysis produces a favourable result.

Does publishing a protocol guarantee publication of the results?

No. A protocol is assessed as a prospective research plan. A later results manuscript requires its own editorial and scientific assessment. This article category does not by itself establish a two-stage Registered Reports process.

Are routine individual case reports included?

They are not an article category. A case series with a defined research question and appropriate methods may fit original research. Authors should explain its purpose and evidence rather than relabel a descriptive individual case.